vay736
Showing 1 - 7 of 7
Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma Trial in
Recruiting
- Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma
- VAY736
- lenalidomide
-
Columbus, Ohio
- +9 more
Aug 1, 2022
Idiopathic Pulmonary Fibrosis Trial in Worldwide (VAY736, Placebo, Standard of Care (SoC))
Completed
- Idiopathic Pulmonary Fibrosis
- VAY736
- +2 more
-
Birmingham, Alabama
- +15 more
Sep 6, 2022
Primary Sjögren's Syndrome Trial in Berlin (VAY736, Placebo)
Completed
- Primary Sjögren's Syndrome
- VAY736
- Placebo
-
Berlin, GermanyNovartis Investigative Site
Sep 30, 2021
Systemic Lupus Erythematosus (SLE) Trial in Worldwide (VAY736, VAY736 Placebo, CFZ533)
Active, not recruiting
- Systemic Lupus Erythematosus (SLE)
- VAY736
- +3 more
-
Ciudad Autonoma de Bs As, Buenos Aires, Argentina
- +31 more
Sep 19, 2022
Pemphigus Vulgaris Trial in Worldwide (VAY736, Placebo)
Terminated
- Pemphigus Vulgaris
- VAY736
- Placebo
-
Chapel Hill, North Carolina
- +4 more
Oct 7, 2021
Relapse Remitting Multiple Sclerosis Trial in Czechia, Ukraine, United States (VAY736, Placebo)
Terminated
- Relapse Remitting Multiple Sclerosis
- VAY736
- Placebo
-
Long Beach, California
- +4 more
Dec 9, 2020
Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Trial in Tampa, Barcelona (VAY736)
Terminated
- Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
- VAY736
-
Tampa, Florida
- +1 more
Feb 27, 2018